5 results about "Antimalarial medication" patented technology

This invention provides the application of Pulsatilla saponin B4 in the preparation of antimalarial drugs, which can significantly improve weight loss, peripheral blood parasitemia, and survival rate in mice infected with lethal Plasmodium. Its mechanism of action is not to directly kill Plasmodium, but to regulate the host immune system, including activating T / B cell immune responses, upregulating pro-inflammatory factors and interferon signaling pathways, and downregulating Arg1 expression. At the same time, Pulsatilla saponin B4 can alleviate immunopathological damage to organs such as the spleen and liver, restore the homeostasis of the spleen's immune microenvironment, and protect the normal structure of tissues. As a natural product, this compound has the characteristics of multiple targets and low toxicity, and has the dual advantages of anti-infection and immune homeostasis regulation, showing good prospects for clinical application and translation.

Disclosed herein are methods and compositions for treating and / or preventing Plasmodium falciparum malaria by administering a compound that mimics the binding of anti-Plasmodium falciparum Glutamic Acid Rich Protein (PfGARP).

This invention belongs to the field of drug synthesis and relates to a highly efficient hydrogen-borrowing reaction strategy for the preparation of ferroquinone (FQ). This strategy uses commercially available ferrocene as a starting material, constructs the key precursor ferrocene diol through two-step conversion, and then proceeds through two hydrogen-borrowing reactions, successfully inventing a highly efficient method for the preparation of FQ in four steps with an overall yield of 69%. Compared with previously reported routes, this method shortens the reaction steps, increases the reaction yield (the overall yield of the existing ferroquinone synthesis route in the background art is 39%), is simpler to operate, and is environmentally friendly (the only byproduct in the hydrogen-borrowing reaction is water). It can be widely used, laying a solid foundation for in-depth pharmacological and physiological activity research of FQ, and providing a novel and universal strategy for developing new scaffolds for candidate drug molecules with high activity and high selectivity of FQ derivatives.

This invention relates to a 6- O -L-arabinopyranosyl- β The preparation of β-D-glucopyranoside and its application in the preparation of antimalarial products belong to the field of traditional Chinese medicine and natural drug pharmaceuticals. Compound 6- of this invention... O -L-arabinopyranosyl- β This invention relates to an antimalarial drug with β-D-glucopyranoside as the active ingredient. It expands the application of aromatic disaccharide compounds 6- from *Hydrangea macrophylla*. O -L-arabinopyranosyl- β The medicinal value of D-glucopyranoside.